Accolade Ownership

ACCD Stock  USD 3.70  0.01  0.27%   
Accolade holds a total of 80.54 Million outstanding shares. The majority of Accolade outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Accolade to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Accolade. Please pay attention to any change in the institutional holdings of Accolade as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2019-03-31
Previous Quarter
78.1 M
Current Value
80.1 M
Avarage Shares Outstanding
60 M
Quarterly Volatility
16.7 M
 
Covid
Some institutional investors establish a significant position in stocks such as Accolade in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Accolade, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of November 22, 2024, Dividend Paid And Capex Coverage Ratio is expected to decline to -1.36. As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 56.2 M. In addition to that, Net Loss is expected to decline to about (53.9 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.

Accolade Stock Ownership Analysis

About 84.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Accolade has Price/Earnings To Growth (PEG) ratio of 1.91. The entity recorded a loss per share of 1.02. The firm had not issued any dividends in recent years. Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people. For more info on Accolade please contact Rajeev Singh at 206 926 8100 or go to https://www.accolade.com.
Besides selling stocks to institutional investors, Accolade also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Accolade's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Accolade's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Accolade Quarterly Liabilities And Stockholders Equity

756.07 Million

Accolade Insider Trades History

Roughly 3.0% of Accolade are currently held by insiders. Unlike Accolade's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Accolade's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Accolade's insider trades
 
Covid

Accolade Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Accolade is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accolade backward and forwards among themselves. Accolade's institutional investor refers to the entity that pools money to purchase Accolade's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-06-30
1.7 M
Dimensional Fund Advisors, Inc.2024-09-30
1.5 M
Prosight Management, Lp2024-06-30
1.5 M
Fairman Group Llc2024-09-30
1.1 M
Jane Street Group Llc2024-06-30
M
Whetstone Capital Advisors, Llc2024-09-30
997.9 K
Clearline Capital Lp2024-06-30
830.8 K
Goldman Sachs Group Inc2024-06-30
776.8 K
Bellevue Group Ag2024-09-30
640.9 K
Blackrock Inc2024-06-30
6.2 M
Ark Investment Management Llc2024-06-30
5.6 M
Note, although Accolade's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Accolade Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Accolade insiders, such as employees or executives, is commonly permitted as long as it does not rely on Accolade's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Accolade insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Accolade Outstanding Bonds

Accolade issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Accolade uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Accolade bonds can be classified according to their maturity, which is the date when Accolade has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Accolade Corporate Filings

F4
20th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
8th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
7th of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.02)
Revenue Per Share
5.706
Quarterly Revenue Growth
0.098
Return On Assets
(0.07)
Return On Equity
(0.19)
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.